In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, according to a preliminary…
Category: 6. Health
-

Drug breakthrough could substantially slow progression of motor neurone disease, say scientists | UK News
Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND).
The drug, named M102, works by protecting nerve cells damaged by MND.
Preclinical studies of…
Continue Reading
-

PCSK9 inhibitor combined with a statin may help reduce LDL cholesterol after heart transplant
The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation…
Continue Reading
-

Study reveals double trouble for peripheral arterial disease patients with AFib
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk of major adverse cardiovascular…
Continue Reading
-

Itchy, dry skin on your hands, face, or knees? It could be eczema; know its causes, types, and symptoms |
Eczema is a common skin condition that causes itching, redness, and irritation, affecting people of all ages. It can appear anywhere on the body and often follows cycles of flare-ups and calm periods. While generally not serious, eczema can…
Continue Reading
-

‘Among adults aged 16 and over’
New data from the Office for National Statistics shows that more people in Britain now use e-cigarettes than smoke traditional cigarettes, for the first time.
What’s happening?
The Independent reported on new statistics from the British government,…
Continue Reading
-

From Research to Practice: Oncology Nurses’ Role in Improving GVHD Tacrolimus Adherence
Adherence to immunosuppressant medication is essential for achieving successful outcomes in graft-vs-host disease (GVHD) management after allogeneic stem cell transplantation (alloSCT). Tacrolimus, the key immunosuppressant, has a narrow…
Continue Reading
-
New Study Links Specific Gut Bacteria to Common Heart Disease – SciTechDaily
- New Study Links Specific Gut Bacteria to Common Heart Disease SciTechDaily
- Can changes in gut bacteria predict the risk of heart disease? MedicalNewsToday
- Recent study links gut health to heart: Here’s how beneficial gut bacteria prevent…
Continue Reading
-

Scottish scientists tackle vampire bat rabies threat in Amazon
Kevin KeaneScotland environment, energy and rural affairs correspondent
Getty ImagesVampire bats are spreading rabies into new areas of the Amazon Scottish scientists in the Amazon are helping to tackle a growing threat from vampire bats, which…
Continue Reading
-
Scientists Finally Figure Out How to Get CBD to the Brain for Pain Relief – SciTechDaily
- Scientists Finally Figure Out How to Get CBD to the Brain for Pain Relief SciTechDaily
- Nano-Formulated CBD Brings Pain Relief To Mice In 30 Minutes Without Side Effects StudyFinds
- Nano Tech Helps CBD Quiet Pain at the Source Neuroscience News
Continue Reading